AAPS Foundation to Promote Drug Development - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

AAPS Foundation to Promote Drug Development



Untitled Document

AAPS announced the launch of the AAPS Foundation, an information network for pharmaceutical scientists around the world. The foundation will help advance the contributions of the pharmaceutical sciences to global health.

The AAPS Foundation will support scientists and initiatives that promote the discovery, development, and manufacture of drugs by attracting and providing resources used to advance research, education, and training. The foundation hopes to assist current pharmaceutical scientists, in addition to expanding and engaging the interests of future generations of scientists.

AAPS Foundation funding priorities will include graduate student fellowships, through AAPS’ strategic partnership with the American Foundation for Pharmaceutical Educations, leaders with a 70-year history in graduate education; Undergraduate Research Grants, in outstanding academic laboratories, to encourage those investigating a research career; multiyear new investigator grants to the most promising young faculty members; a Leadership Institute to ensure that current students and research professionals will thrive in the pharmaceutical industry, academia, or government; and a Teach the Teacher program, developed to increase outreach to K-12 students and also establish ongoing relationships with high school science and math teachers around the country and globe.

Source: AAPS

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here